pyrroles has been researched along with Adenocystic Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Brana, I; Brown, RJ; Doger, B; Galvao, V; Genta, S; Gu, J; Hansen, AR; Hernández, T; Kalota, A; Lauring, J; Lenox, L; Mehta, J; Mistry, P; Moreno, V; Pastore, F; Patel, B; Patel, MR; Preis, M; Spreafico, A; Vieito, M; Wang, JS | 1 |
Liang, LZ; Liang, YJ; Liao, GQ; Liu, HC; Ma, B; Su, YX; Zhang, TH; Zheng, GS | 1 |
Chau, NG; Chen, EX; Chin, SF; Hotte, SJ; Siu, LL; Turner, S; Wang, L | 1 |
2 trial(s) available for pyrroles and Adenocystic Carcinoma
Article | Year |
---|---|
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors.
Topics: Adult; Carcinoma, Adenoid Cystic; Humans; Lymphoma, Non-Hodgkin; Neoplasms; Protein-Arginine N-Methyltransferases; Pyrimidines; Pyrroles | 2023 |
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly targeted agents in ACC.
Topics: Adult; Aged; Angiogenesis Inhibitors; Carcinoma, Adenoid Cystic; Disease-Free Survival; Female; Humans; Indoles; Kaplan-Meier Estimate; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Proto-Oncogene Mas; Pyrroles; Salivary Gland Neoplasms; Sunitinib; Treatment Outcome | 2012 |
1 other study(ies) available for pyrroles and Adenocystic Carcinoma
Article | Year |
---|---|
Obatoclax induces Beclin 1- and ATG5-dependent apoptosis and autophagy in adenoid cystic carcinoma cells.
Topics: Autophagy; Autophagy-Related Protein 5; Beclin-1; Carcinoma, Adenoid Cystic; Cell Line, Tumor; Cell Survival; Humans; Indoles; Prognosis; Pyrroles; Salivary Gland Neoplasms | 2015 |